NovoCure Ltd

NovoCure Ltd

NVCR

Market Cap$2.43B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
NovoCure LtdNovoCure Ltd-16.2--42%4.41.8
$30.00

Target Price by Analysts

36.1% upsideNovoCure Ltd Target Price DetailsTarget Price
$1.20

Current Fair Value

94.5% downside

Overvalued by 94.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.43 Billion
Enterprise Value$2.90 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.95
Beta0.62
Outstanding Shares108,247,716

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-16.25
PEG42.5
Price to Sales4.41
Price to Book Ratio7.35
Enterprise Value to Revenue5.02
Enterprise Value to EBIT-25.34
Enterprise Value to Net Income-20
Total Debt to Enterprise0.23
Debt to Equity1.81

Revenue Sources

No data

Insider Trades

ESG Score

No data

About NovoCure Ltd

CEO: Asaf Danziger